DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Mallinckrodt Beats Q1 Earnings, Ups View - Analyst Blog

Earnings Beat at Lannett, Shares Up - Analyst Blog

Which Indian ADRs Are Shining Despite the Country's Slowdown?

Check out Infosys, Dr. Reddy's Laboratories, and Wipro. You'll be surprised.

Teva Beats on Q4 Earnings & Revs, Affirms View - Analyst Blog

Earnings Grow Year over Year at Celgene - Analyst Blog

A Comprehensive Look At Galena

Galena Partners With Other Companies And Offers Even More Strength Going Forward

New Lifetime High For Dr. Reddy Laboratories (RDY)

Galena Biopharma, Dr. Reddy's Sign NeuVax Licensing Pact for India

Dr. Reddy's Laboratories will hold the commercial rights for Galena's NeuVax, and head the development of the drug to treat gastric cancer.

Post-TEVA Deal, ANIP Shares Rise - Analyst Blog

Post-TEVA Deal, ANIP Shares Rise - Analyst Blog